These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12797485)

  • 21. [Diagnostic value of serum procalcitonin in identifying the etiology of non-responding community-acquired pneumonia after initial antibiotic therapy].
    Wang Z; Zhang X; Wu J; Zhang W; Kuang H; Li X; Xuan W; Wang K; Ma L
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Nov; 37(11):824-30. PubMed ID: 25604112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.
    Müller B; Harbarth S; Stolz D; Bingisser R; Mueller C; Leuppi J; Nusbaumer C; Tamm M; Christ-Crain M
    BMC Infect Dis; 2007 Mar; 7():10. PubMed ID: 17335562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Procalcitonin in Differential Diagnosis of Pneumonia and Pulmonary Congestion Associated With End-Stage Renal Failure.
    Akçay Ş; Doğrul I; Sezer S; Haberal M
    Exp Clin Transplant; 2016 Nov; 14(Suppl 3):71-73. PubMed ID: 27805517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers in community-acquired pneumonia.
    Krüger S; Welte T
    Expert Rev Respir Med; 2012 Apr; 6(2):203-14. PubMed ID: 22455492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of C-reactive protein and procalcitonin in suspected community-acquired pneumonia adults visiting emergency department and having a systematic thoracic CT scan.
    Le Bel J; Hausfater P; Chenevier-Gobeaux C; Blanc FX; Benjoar M; Ficko C; Ray P; Choquet C; Duval X; Claessens YE;
    Crit Care; 2015 Oct; 19():366. PubMed ID: 26472401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of procalcitonin level in community-acquired pneumonia in the ED.
    Park JH; Wee JH; Choi SP; Oh SH
    Am J Emerg Med; 2012 Sep; 30(7):1248-54. PubMed ID: 22030193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia.
    Ramírez P; Ferrer M; Martí V; Reyes S; Martínez R; Menéndez R; Ewig S; Torres A
    Crit Care Med; 2011 Oct; 39(10):2211-7. PubMed ID: 21705887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study.
    Piacentini E; Sánchez B; Arauzo V; Calbo E; Cuchi E; Nava JM
    J Crit Care; 2011 Apr; 26(2):201-5. PubMed ID: 20813489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Procalcitonin: inflammatory biomarker for assessing the severity of community-acquired pneumonia--a clinical observation in geriatric patients.
    Heppner HJ; Bertsch T; Alber B; Esslinger AS; Dragonas C; Bauer JM; Sieber CC
    Gerontology; 2010; 56(4):385-9. PubMed ID: 19940454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia.
    Claessens YE; Mathevon T; Kierzek G; Grabar S; Jegou D; Batard E; Loyer C; Davido A; Hausfater P; Robert H; Lavagna-Perez L; Bernot B; Plaisance P; Leroy C; Renaud B
    Intensive Care Med; 2010 May; 36(5):799-809. PubMed ID: 20232049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of usefulness of plasma procalcitonin and C-reactive protein measurements for estimation of severity in adults with community-acquired pneumonia.
    Hirakata Y; Yanagihara K; Kurihara S; Izumikawa K; Seki M; Miyazaki Y; Kohno S
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):170-4. PubMed ID: 18329217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of serum procalcitonin in differential diagnosis of pulmonary embolism and community-acquired pneumonia.
    Köktürk N; Kanbay A; Bukan N; Ekim N
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):519-25. PubMed ID: 20699253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic value of serum procalcitonin and C-reaction protein in acute exacerbation of chronic bronchitis].
    Hu XJ; Zhou F; Qiu YR; Li Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1618-20. PubMed ID: 20650783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study.
    Mendelson F; Griesel R; Tiffin N; Rangaka M; Boulle A; Mendelson M; Maartens G
    BMC Infect Dis; 2018 Aug; 18(1):399. PubMed ID: 30107791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood.
    Don M; Valent F; Korppi M; Falleti E; De Candia A; Fasoli L; Tenore A; Canciani M
    Scand J Infect Dis; 2007; 39(2):129-37. PubMed ID: 17366029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia.
    Brunkhorst FM; Al-Nawas B; Krummenauer F; Forycki ZF; Shah PM
    Clin Microbiol Infect; 2002 Feb; 8(2):93-100. PubMed ID: 11952722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
    Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
    Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Utility of serum procalcitonin as a diagnostic guide in children with community-acquired pneumonia].
    García-Zarza Martínez E; Ramos Amador JT; Rubio Gribble B; Corrales del Río E; Zeballos Sarrato G; Herrera Montes J
    An Pediatr (Barc); 2004 Mar; 60(3):279-81. PubMed ID: 14987523
    [No Abstract]   [Full Text] [Related]  

  • 39. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.
    Falsey AR; Becker KL; Swinburne AJ; Nylen ES; Snider RH; Formica MA; Hennessey PA; Criddle MM; Peterson DR; Walsh EE
    Int J Chron Obstruct Pulmon Dis; 2012; 7():127-35. PubMed ID: 22399852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.
    Schuetz P; Christ-Crain M; Wolbers M; Schild U; Thomann R; Falconnier C; Widmer I; Neidert S; Blum CA; Schönenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Müller B;
    BMC Health Serv Res; 2007 Jul; 7():102. PubMed ID: 17615073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.